France· FR:60251352
PIPERACILLINE PANPHARMA 1 g, poudre pour solution injectable (I.M., I.V.)
A piperacillin product containing pipéracilline sodique, registered in France by PANPHARMA. The same ATC class is registered in 5 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Piperacillin is registered in 5 of 19 countries.
Countries holding a registration under ATC J01CA12 (piperacillin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 3 of them publish a price we can compare per daily dose
Piperacillin · ATC J01CA12
5 / 19 countries
- Finlandprice
- Franceprice
- Germany
- Italyprice
- Japan
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PIPÉRACILLINE SODIQUE
- Manufacturer
- PANPHARMA
- Country
- France (FR)
- ATC code
- J01CA12
- ATC class
- Piperacillin
- Defined daily dose
- 14 g, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009560830911 g en flacon(s) verre de 15 ml, boîte de 1 flacon
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
111 interactions on record for piperacillin.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Piperacillin · interactions on record
111 records
- 5 severe
- 22 moderate
- 4 minor
- 80 info
Most severe, free to view
- VancomycinA07AA09severe
- VancomycinJ01XA01severe
- MethotrexateL01BA01severe
- MethotrexateL04AX03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Piperacillin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumPiperacillin/Tazobactam Eugia 2 g - 250 mgEugia Pharma (Malta)
- Japanピペラシリンナトリウム日医工岐阜工場
- ItalyPIPERACILLINA SODICAK24 PHARMACEUTICALS S.R.L.
- GermanyPiperacillin FreseniusFresenius Kabi Deutschland Gmbh
- FinlandPiprilWyeth Lederle Nordiska Ab
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Italy · Piperacillina K24 Pharmaceuticals, Piperital
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/82f691bf-7bee-4c36-a2c9-6607b67dd758 GET /v1/drugs/82f691bf-7bee-4c36-a2c9-6607b67dd758?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60251352",
"date_amm": "1997-12-05",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "PIPÉRACILLINE SODIQUE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution injectable",
"voies_administration": "intramusculaire;intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about piperacillin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.